BDBM357015 US10214511, Example 19::US10676460, Example 19

SMILES Clc1nc(NCc2ccccn2)c2c(cccc2n1)-c1ccccc1

InChI Key InChIKey=JSYVMXAHYRRFOQ-UHFFFAOYSA-N

Data  50 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 50 hits for monomerid = 357015   

TargetInsulin-like growth factor 1 receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.76E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetInsulin-like growth factor 1 receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.76E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetInhibitor of nuclear factor kappa-B kinase subunit epsilon(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.87E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetAurora kinase A(Mouse)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 3.98E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 3.38E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.92E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 5 activator 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetCasein kinase I isoform alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha'(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 2.55E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.15E+3nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.78E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 2.38E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetAurora kinase B(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 3.98E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 3.38E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 50nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase kinase kinase 8(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.19E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent

TargetPotassium voltage-gated channel subfamily H member 2(Human)
Bristol-Myers Squibb

Curated by ChEMBL
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 8.00E+4nMAssay Description:Inhibition of human ERG expressed in HEK293 cells by thallium flux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetPotassium voltage-gated channel subfamily A member 5(Human)
Bristol-Myers Squibb

Curated by ChEMBL
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 70nMAssay Description:Inhibition of human Kv1.5 transfected in mouse LTK cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/27/2021
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 2.55E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.15E+3nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetInsulin-like growth factor 1 receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.76E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetInhibitor of nuclear factor kappa-B kinase subunit epsilon(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetInterleukin-1 receptor-associated kinase 4(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.87E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetAurora kinase A(Mouse)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 3.98E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 3.38E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase BTK(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.92E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 5(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetCyclin-dependent kinase 5 activator 1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetCasein kinase I isoform alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetCasein kinase II subunit alpha(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.01E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetInsulin-like growth factor 1 receptor(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.76E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.78E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetTyrosine-protein kinase JAK3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 2.38E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetAurora kinase A(Mouse)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 3.98E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase pim-1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 3.38E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase PLK1(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 50nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase kinase kinase 8(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.19E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 5.00E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
Go to US Patent

TargetVascular endothelial growth factor receptor 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM357015(US10214511, Example 19 | US10676460, Example 19)
Affinity DataIC50: 1.01E+4nMAssay Description:The analyses were performed in U-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme and subst...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2021
Entry Details
Go to US Patent